SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q3 2022
Institutional positions in SAB Biotherapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +3 vs. Q2 2022
- Shares held
- 3.31M
- +227.0K (+7.4%) vs. Q2 2022
- Total value
- $2.32M
- −$2.13M (−47.9%) vs. Q2 2022
- New holders
- 6
- 10 more added
- Sold out
- 3
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First PREMIER Bank | 807,535 | $566.0K | 0.18% | +155,095+23.8% | Added |
| Vanguard Group Inc | 701,003 | $491.0K | 0.00% | −20,648−2.9% | Reduced |
| Geode Capital Management, LLC | 316,663 | $221.0K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 275,000 | $193.0K | 0.01% | 00.0% | Unchanged |
| Meteora Capital, LLC | 249,525 | $175.0K | 0.04% | −43,013−14.7% | Reduced |
| Institutional & Family Asset Management, LLC | 149,774 | $105.0K | 0.02% | +71,659+91.7% | Added |
| BlackRock Inc. | 125,722 | $88.0K | 0.00% | −1,724−1.4% | Reduced |
| Bridgeway Capital Management, LLC | 84,000 | $59.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,241 | $57.0K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 69,000 | $48.0K | 0.00% | +69,000 | New |
| Creative Planning | 47,518 | $33.0K | 0.00% | +990+2.1% | Added |
| Northern Trust Corp | 44,476 | $31.0K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 43,551 | $31.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 40,162 | $28.0K | 0.00% | +40,162 | New |
| Millennium Management LLC | 38,547 | $27.0K | 0.00% | −25,673−40.0% | Reduced |
| Morgan Stanley | 25,071 | $18.0K | 0.00% | +319+1.3% | Added |
| Jane Street Group, LLC | 23,954 | $17.0K | 0.00% | +23,954 | New |
| LGL Partners, LLC | 23,000 | $16.0K | 0.00% | 00.0% | Unchanged |
| AE Wealth Management LLC | 18,700 | $13.0K | 0.00% | 00.0% | Unchanged |
| Brookstone Capital Management | 16,465 | $13.0K | 0.00% | −3,153−16.1% | Reduced |
| American Portfolios Advisors | 17,466 | $12.2K | 0.00% | +17,466 | New |
| Charles Schwab Investment Management Inc | 16,238 | $12.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 13,642 | $10.0K | 0.00% | +5,466+66.9% | Added |
| Goldman Sachs Group Inc | 12,618 | $9.00K | 0.00% | −1,844−12.8% | Reduced |
| Elgethun Capital Management | 13,296 | $9.00K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 11,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| 1st Source Bank | 10,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9,000 | $6.00K | 0.00% | +9,000 | New |
| Spectrum Management Group, LLC | 5,030 | $4.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,119 | $3.00K | 0.00% | +299+6.2% | Added |
| Wolverine Asset Management LLC | 3,926 | $2.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,625 | $2.00K | 0.00% | +817+45.2% | Added |
| Advisor Group Holdings, Inc. | 2,213 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,504 | $1.00K | 0.00% | +504+50.4% | Added |
| Rockefeller Capital Management L.P. | 1,500 | $1.00K | 0.00% | +300+25.0% | Added |
| Bank of America Corp | 470 | $0 | 0.00% | −306−39.4% | Reduced |
| Citigroup Inc | 494 | $0 | 0.00% | −145−22.7% | Reduced |
| Wells Fargo & Company | 180 | $0 | 0.00% | +13+7.8% | Added |
| Daiwa Securities Group Inc. | 127 | $0 | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 403 | $0 | 0.00% | +403 | New |
| Silver Oak Securities, Inc | 0 | $0 | 0.00% | −51,941−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −13,581−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −6,405−100.0% | Sold out |